|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| C07K 16/26 | (2006.01) |
| (11) | Number of the document | 2579894 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11792989.3 |
| Date of filing the European patent application | 2011-06-07 | |
| (97) | Date of publication of the European application | 2013-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (86) | Number | PCT/US2011/039381 |
| Date | 2011-06-07 |
| (87) | Number | WO 2011/156324 |
| Date | 2011-12-15 |
| (30) | Number | Date | Country code |
| 353323 P | 2010-06-10 | US |
| (72) |
ALLAN, Barrett, US
BENSCHOP, Robert Jan, US
CHAMBERS, Mark Geoffrey, US
DARLING, Ryan James, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | CGRP antikūnai |
| CGRP ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 15 | 289.00 EUR |
| 2026-06-07 |